Cargando…
Immunological Evaluation of Lipopeptide Group A Streptococcus (GAS) Vaccine: Structure-Activity Relationship
Streptococcus pyogenes (group A streptococcus, GAS) is a Gram-positive bacterial pathogen responsible for a wide variety of diseases. To date, GAS vaccine development has focused primarily on the M-protein. The M-protein is highly variable at the amino (N)-terminus (determining serotype) but is cons...
Autores principales: | Zaman, Mehfuz, Abdel-Aal, Abu-Baker M., Fujita, Yoshio, Phillipps, Karen S. M., Batzloff, Michael R., Good, Michael F., Toth, Istvan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257266/ https://www.ncbi.nlm.nih.gov/pubmed/22253911 http://dx.doi.org/10.1371/journal.pone.0030146 |
Ejemplares similares
-
Immunostimulation by Synthetic Lipopeptide-Based Vaccine Candidates: Structure-Activity Relationships
por: Zaman, Mehfuz, et al.
Publicado: (2013) -
Novel platform technology for modular mucosal vaccine that protects against streptococcus
por: Zaman, Mehfuz, et al.
Publicado: (2016) -
Mechanism of Protection Induced by Group A Streptococcus Vaccine Candidate J8-DT: Contribution of B and T-Cells Towards Protection
por: Pandey, Manisha, et al.
Publicado: (2009) -
Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models
por: Langshaw, Emma L., et al.
Publicado: (2023) -
Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial
por: Pandey, Manisha, et al.
Publicado: (2017)